FDA Globalization Act Earns Support for Inspections, Concern Over Details

Drug Industry Daily
A A
While more overseas inspections of drugmaking facilities and more funds for them secured industry and bipartisan political support at yesterday’s hearing on a draft bill to enhance the FDA’s authority, a number of the draft’s provisions drew criticism.

To View This Article:

Login

Subscribe To Drug Industry Daily